Trial intelligence / Profile preview

Gabapentin enacarbil in Japanese RLS patients

NCT02658188Phase 3Completed

Sponsor
Astellas Pharma
Start
Dec 2007
Primary completion
Apr 2009
Countries
1
01

Overview

A Phase 3 trial of gabapentin enacarbil in restless legs syndrome (RLS), sponsored by Astellas Pharma. Started Dec 2007; status: completed.

02

Drugs

gabapentin enacarbil
03

Conditions

restless legs syndrome (RLS)

Beyond the preview

Go deeper on NCT02658188.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02658188.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call